The critical need for cancer biometrics: quantitative, reproducible measures of cancer to define response to therapy.
Lotze
Michael T
MT
D001699:Biometry / Q000379:methods; D016503:Drug Delivery Systems / Q000379:methods* / Q000639:trends; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics; D040901:Proteomics / Q000379:methods; D015203:Reproducibility of Results; D013678:Technology, Pharmaceutical / Q000379:methods / Q000639:trends